Arbutus Biopharma

ABUSNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$991.218 M

$5.01 +0.20%

Close of 22 Sept 2026

Revenue

$14.1M

#3082 by revenue

Earnings

-$33.5M

Loss-making

Shares outstanding

197,847,835

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#157Kura OncologyKURA$1.04B
#158Amphastar PharmaceuticalsAMPH$1.03B
#159Arbutus BiopharmaABUS$991.2M
#160Pacira BioSciencesPCRX$984.6M
#161Lexicon PharmaceuticalsLXRX$970.0M

What if Arbutus Biopharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$152,814.26

Per share 30,502× higher

Bitcoin $1.74T

$8,803.00

Per share 1,757× higher

Nvidia $5.52T

$27,878.83

Per share 5,565× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Arbutus Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.